Search

Author/Creator Lancaster, Lisa

1. Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis. Issue 5 (11th March 2016)

Authors:
Nathan, Steven D; Albera, Carlo; Bradford, Williamson Z; Costabel, Ulrich; du Bois, Roland M; Fagan, Elizabeth A; Fishman, Robert S; Glaspole, Ian; Glassberg, Marilyn K; Glasscock, Kenneth F; King, Talmadge E; Lancaster, Lisa; Lederer, David J; Lin, Zhengning; Pereira, Carlos A; Swigris, Jeffrey ...
Journal:
Thorax
Issue:
Volume 71:Issue 5(2016)
Page Start:
429
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function. Issue 3 (28th July 2016)

Authors:
Albera, Carlo; Costabel, Ulrich; Fagan, Elizabeth A.; Glassberg, Marilyn K.; Gorina, Eduard; Lancaster, Lisa; Lederer, David J.; Nathan, Steven D.; Spirig, Dominique; Swigris, Jeff J.
Journal:
European respiratory journal
Issue:
Volume 48:Issue 3(2016)
Page Start:
843
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis. Issue 5 (10th March 2016)

Authors:
Raghu, Ganesh; Scholand, Mary Beth; de Andrade, João; Lancaster, Lisa; Mageto, Yolanda; Goldin, Jonathan; Brown, Kevin K.; Flaherty, Kevin R.; Wencel, Mark; Wanger, Jack; Neff, Thomas; Valone, Frank; Stauffer, John; Porter, Seth
Journal:
European respiratory journal
Issue:
Volume 47:Issue 5(2016)
Page Start:
1481
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia. Issue 1 (December 2016)

Authors:
Fingerlin, Tasha; Zhang, Weiming; Yang, Ivana; Ainsworth, Hannah; Russell, Pamela; Blumhagen, Rachel; Schwarz, Marvin; Brown, Kevin; Steele, Mark; Loyd, James; Cosgrove, Gregory; Lynch, David; Groshong, Steve; Collard, Harold; Wolters, Paul; Bradford, Williamson; Kossen, Karl; Seiwert, Scott; du ...
Journal:
BMC genetics
Issue:
Volume 17:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD). Issue 1 (30th December 2021)

Authors:
Corte, Tamera J; Lancaster, Lisa; Swigris, Jeffrey J; Maher, Toby M; Goldin, Jonathan G; Palmer, Scott M; Suda, Takafumi; Ogura, Takashi; Minnich, Anne; Zhan, Xiaojiang; Tirucherai, Giridhar S; Elpers, Brandon; Xiao, Hong; Watanabe, Hideaki; Smith, R Adam; Charles, Edgar D; Fischer, Aryeh
Journal:
BMJ open respiratory research
Issue:
Volume 8:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. Issue 1 (January 2016)

Authors:
Noble, Paul W.; Albera, Carlo; Bradford, Williamson Z.; Costabel, Ulrich; du Bois, Roland M.; Fagan, Elizabeth A.; Fishman, Robert S.; Glaspole, Ian; Glassberg, Marilyn K.; Lancaster, Lisa; Lederer, David J.; Leff, Jonathan A.; Nathan, Steven D.; Pereira, Carlos A.; Swigris, Jeffrey J.; Valeyre, ...
Journal:
European respiratory journal
Issue:
Volume 47:Issue 1(2016)
Page Start:
243
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials. Issue 1 (25th March 2019)

Authors:
Lancaster, Lisa; Crestani, Bruno; Hernandez, Paul; Inoue, Yoshikazu; Wachtlin, Daniel; Loaiza, Lazaro; Quaresma, Manuel; Stowasser, Susanne; Richeldi, Luca
Journal:
BMJ open respiratory research
Issue:
Volume 6:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials. Issue 1 (12th January 2016)

Authors:
Lancaster, Lisa; Albera, Carlo; Bradford, Williamson Z; Costabel, Ulrich; du Bois, Roland M; Fagan, Elizabeth A; Fishman, Robert S; Glaspole, Ian; Glassberg, Marilyn K; King, Talmadge E; Lederer, David J; Lin, Zhengning; Nathan, Steven D; Pereira, Carlos A; Swigris, Jeffrey J; Valeyre, Dominique;...
Journal:
BMJ open respiratory research
Issue:
Volume 3:Issue 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis. Issue 1 (4th July 2022)

Authors:
Nathan, Steven D; Behr, Jurgen; Cottin, Vincent; Lancaster, Lisa; Smith, Peter; Deng, CQ; Pearce, Natalie; Bell, Heidi; Peterson, Leigh; Flaherty, Kevin R
Journal:
BMJ open respiratory research
Issue:
Volume 9:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗